HomeOCX • NASDAQ
add
OncoCyte Corp
Previous close
$2.26
Day range
$2.13 - $2.32
Year range
$1.97 - $3.57
Market cap
37.21M USD
Avg Volume
110.59K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 115.00K | -73.19% |
Operating expense | 6.45M | 19.46% |
Net income | -13.49M | -107.94% |
Net profit margin | -11.73K | -675.69% |
Earnings per share | — | — |
EBITDA | -6.04M | -28.38% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.36M | -76.36% |
Total assets | 70.22M | -13.94% |
Total liabilities | 60.50M | 54.74% |
Total equity | 9.71M | — |
Shares outstanding | 16.84M | — |
Price to book | 3.10 | — |
Return on assets | -21.99% | — |
Return on capital | -79.54% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -13.49M | -107.94% |
Cash from operations | -5.55M | -47.28% |
Cash from investing | -87.00K | -140.65% |
Cash from financing | -255.00K | -750.00% |
Net change in cash | -5.89M | -64.38% |
Free cash flow | -2.38M | -67.64% |
About
Founded
2009
Headquarters
Website
Employees
45
